e-learning
resources
Breathe
2020
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High-flow therapy: physiological effects and clinical applications
Rebecca F. D'Cruz, Nicholas Hart, Georgios Kaltsakas
Source:
Breathe, 16 (4) 200224; 10.1183/20734735.0224-2020
Journal Issue:
December
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Rebecca F. D'Cruz, Nicholas Hart, Georgios Kaltsakas. High-flow therapy: physiological effects and clinical applications. Breathe, 16 (4) 200224; 10.1183/20734735.0224-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Update on novel anticoagulants: indications, dosing alternatives and outcomes
Source: International Congress 2018 – Pulmonary embolism: what we need to know
Year: 2018
Assessing the effect of medical therapy in COPD: from pathophysiology and biomarkers to clinical practice
Source: Annual Congress 2009 - PG15 The complexity of COPD: assessment and advanced therapies
Year: 2009
Clinical implications and novel therapies
Source: International Congress 2018 – Accelerated ageing in lungs
Year: 2018
Bronchodiator therapy in COPD: physiological effects
Source: Breathe 2008; 4: 342-344
Year: 2008
COPD mechanisms: novel aspects and implications for new therapies
Source: ERS Live 2007
Year: 2007
COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness
Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020
Year: 2020
Comparative efficacy of the therapy strategies for the asthma control maintenance in real clinical practice
Source: Annual Congress 2011 - Asthma: control and treatment
Year: 2011
Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials
Source: Eur Respir J 2015; 46: 243-249
Year: 2015
COVID-19 vaccines: immunology, regulation and clinical management
Source: Eur Respir Monogr 2021; 94: 244-260
Year: 2021
At the interface: the translational science supporting the clinical use of anti-cytokine therapy
Source: International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost?
Year: 2018
Our experience of 200 patients: Usage and maintenance of long-term oxygen therapy and non-invasive ventilation devices at home
Source: Annual Congress 2013 –Long-term NIV: COPD, sleep, obesity and outcomes
Year: 2013
Biologics: current use and future applications for personalised therapy
Source: Virtual Congress 2021 – Wheezing illnesses along the life span
Year: 2021
Novel paradigm for inhaled therapies: simulation of drug pharmacokinetic behaviour and effect of disease
Source: Eur Respir J 2003; 22: Suppl. 45, 474s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept